Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›NOI - DNA Sequencing of Bone Marrow Failure Syndro

U.S. Department Of Health And Human Services·Maryland

NOI - DNA Sequencing of Bone Marrow Failure Syndro

Closes 11/2/2026$50k – $200kRequest for Quotation
Get bids like this by emailBid source

Description

The National Institutes of Health (NIH) is seeking quotations for custom‑designed ArcherDX VariantPlex next‑generation sequencing (NGS) library preparation kits to support screening of over 200 bone‑marrow‑failure patient samples. The kits must use ArcherDX’s proprietary AMP chemistry, include unique molecular barcodes for error‑correcting sequencing, be compatible with Illumina NovaSeq platforms, and integrate with the existing Archer Analysis bioinformatics pipeline. Delivery is required to the NIH/NHLBI Hematology Branch in Bethesda, MD, with an estimated lead time of 4–6 weeks after order receipt. The solicitation is non‑competitive, but all responsible sources may submit a quote; the intent is to award to Integrated DNA Technologies, Inc. • Product: ArcherDX VariantPlex NGS library prep kits (custom panel). • Quantity: Sufficient for > 200 samples (exact count not specified). • Delivery location: NIH/NHLBI, Bethesda, MD. • Contract type: Firm‑fixed‑price purchase order, non‑competitive. • Deadline for quote submission: 2 Nov 2026 09:00 EST.

Attached files

Contact

Nicholas S. Capobianco(Contracting Specialist)

[email protected]

(000) 000-0000

Key dates

Opened
10/22/2026
Closes
11/2/2026
Duration
4 weeks

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
325413
Solicitation №
75N98027Q00027

Budget estimate

$50,000 – $200,000

No contract value is disclosed. Based on typical pricing for custom NGS library preparation kits (approximately $400‑$800 per kit) and the need for enough kits to process >200 samples, the total procurement could range from roughly $80,000 to $160,000. Including shipping, handling, and potential volume discounts, a reasonable estimate for the award value is $50,000‑$200,000.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 78%

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

78% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

77% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

77% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. National Institutes of Health·United States of America

77% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Department Of Health And Human Services·Maryland

77% match

Reagents and consumables for Roche immunostainers

Closes 10/28/2026Opened 10/22/2026

U.S. National Institutes of Health·United States of America

77% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

U.S. Department Of Health And Human Services·Maryland

77% match

NOI - 4D-Nucleofector Core Unit and X Unit

Closes 11/5/2026Opened 10/22/2026

U.S. National Institutes of Health·United States of America

76% match

RNomics Technology Enhancement Centers

Closes 1/31/2027Opened 8/5/2026

U.S. Department Of The Interior·Michigan

76% match

B--METAGENOMICS & TRANSCRIPTOMIC SERVICES

Closes 10/28/2026Opened 10/8/2026

U.S. National Institutes of Health·United States of America

76% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

76% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

76% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

76% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. Department Of Veterans Affairs·Maryland

76% match

6550--Cepheid GeneXpert Testing Supplies

Closes 11/16/2026Opened 9/22/2026

U.S. National Institutes of Health·United States of America

76% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. National Institutes of Health·United States of America

76% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. National Institutes of Health·United States of America

76% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

75% match

DoW Bone Marrow Failure, Resource Development Award

Closes 11/4/2026Opened 6/17/2026

U.S. National Institutes of Health·United States of America

75% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

75% match

GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

Closes 10/30/2026Opened 6/6/2025

U.S. Department Of Defense·Maryland

75% match

Notice of Intent DNA Synthesizer

Closes 11/2/2026Opened 10/15/2026

LA County Sheriff·California

75% match

RFSQ - DNA Laboratory Services

Rolling / TBD closeOpened 11/9/2021

U.S. Department Of The Interior·Michigan

75% match

Q--AMPLICON SEQUENCING SERVICES

Closes 11/5/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

75% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026